Frank von Delft

Prof. Frank von Delft

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2000 in Nature
Verified
Journal Article
Closed access
PDF file
LPLuca Pellegrini
Luca Pellegrini
DBDavid Burke
David Burke
FDFrank von Delft
Frank von Delft
BMBarbara Mulloy
Barbara Mulloy
TBTom L. Blundell
Tom L. Blundell

1 February 2018 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
LPLiz Potterton
Liz Potterton
JAJon Agirre
Jon Agirre
CBCharles Ballard
Charles Ballard
KCKevin Cowtan
Kevin Cowtan
EDEleanor Dodson
Eleanor Dodson
MWMarcin Wojdyr
Marcin Wojdyr
TheCCP4 (Collaborative Computational Project, Number 4) software suite for macromolecular structure determination by X-ray crystallography groups brings together many programs and libraries that, by means of well established conventions, interoperate effectively without adhering to strict design guidelines. Because of this inherent flexibility, users are often presented with diverse, even divergent, choices for solving every type of problem. Recently, CCP4 introducedCCP4i2, a modern graphical interface designed to help structural biologists to navigate the process of structure determination, with an emphasis on pipelining and the streamlined presentation of results. In addition,CCP4i2 provides a framework for writing structure-solution scripts that can be built up incrementally to create increasingly automatic procedures.

7 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ADAlice Douangamath
Alice Douangamath
DFDaren Fearon
Daren Fearon
PGPaul Gehrtz
Paul Gehrtz
TKTobias Krojer
Tobias Krojer
PLPetra Lukacik
Petra Lukacik
MWMartin Walsh
Martin Walsh
COVID-19, caused by SARS-CoV-2, lacks effective therapeutics. Additionally, no antiviral drugs or vaccines were developed against the closely related coronavirus, SARS-CoV-1 or MERS-CoV, despite previous zoonotic outbreaks. To identify starting points for such therapeutics, we performed a large-scale screen of electrophile and non-covalent fragments through a combined mass spectrometry and X-ray approach against the SARS-CoV-2 main protease, one of two cysteine viral proteases essential for viral replication. Our crystallographic screen identified 71 hits that span the entire active site, as well as 3 hits at the dimer interface. These structures reveal routes to rapidly develop more potent inhibitors through merging of covalent and non-covalent fragment hits; one series of low-reactivity, tractable covalent fragments were progressed to discover improved binders. These combined hits offer unprecedented structural and reactivity information for on-going structure-based drug design against SARS-CoV-2 main protease.

7 May 2019 in Journal of the American Chemical Society
Verified
Journal Article
Open access
EREfrat Resnick
Efrat Resnick
ABAnthony Bradley
Anthony Bradley
JGJinrui Gan
Jinrui Gan
ADAlice Douangamath
Alice Douangamath
TKTobias Krojer
Tobias Krojer
NLNir London
Nir London
Covalent probes can display unmatched potency, selectivity, and duration of action; however, their discovery is challenging. In principle, fragments that can irreversibly bind their target can overcome the low affinity that limits reversible fragment screening, but such electrophilic fragments were considered nonselective and were rarely screened. We hypothesized that mild electrophiles might overcome the selectivity challenge and constructed a library of 993 mildly electrophilic fragments. We characterized this library by a new high-throughput thiol-reactivity assay and screened them against 10 cysteine-containing proteins. Highly reactive and promiscuous fragments were rare and could be easily eliminated. In contrast, we found hits for most targets. Combining our approach with high-throughput crystallography allowed rapid progression to potent and selective probes for two enzymes, the deubiquitinase OTUB2 and the pyrophosphatase NUDT7. No inhibitors were previously known for either. This study highlights the potential of electrophile-fragment screening as a practical and efficient tool for covalent-ligand discovery.

24 April 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
NPNicholas M. Pearce
Nicholas M. Pearce
TKTobias Krojer
Tobias Krojer
ABAnthony R. Bradley
Anthony R. Bradley
PCPatrick Collins
Patrick Collins
RNRadosław P. Nowak
Radosław P. Nowak
FDFrank von Delft
Frank von Delft
In macromolecular crystallography, the rigorous detection of changed states (for example, ligand binding) is difficult unless signal is strong. Ambiguous (‘weak’ or ‘noisy’) density is experimentally common, since molecular states are generally only fractionally present in the crystal. Existing methodologies focus on generating maximally accurate maps whereby minor states become discernible; in practice, such map interpretation is disappointingly subjective, time-consuming and methodologically unsound. Here we report the PanDDA method, which automatically reveals clear electron density for the changed state—even from inaccurate maps—by subtracting a proportion of the confounding ‘ground state’; changed states are objectively identified from statistical analysis of density distributions. The method is completely general, implying new best practice for all changed-state studies, including the routine collection of multiple ground-state crystals. More generally, these results demonstrate: the incompleteness of atomic models; that single data sets contain insufficient information to model them fully; and that accuracy requires further map-deconvolution approaches.

24 June 2007 in Nature
Verified
Journal Article
Closed access
PDF file
SNStanley S. Ng
Stanley S. Ng
KKKathryn L. Kavanagh
Kathryn L. Kavanagh
MMMichael A. McDonough
Michael A. McDonough
DBDanica Butler
Danica Butler
EPEwa S. Pilka
Ewa S. Pilka
UOUdo Oppermann
Udo Oppermann